STI Epidemiology and Screening in Adolescents

Adolescents and young adults carry a share of new sexually transmitted infections far out of proportion to their numbers, and a large fraction of these infections cause no symptoms. This combination is the central reason screening, rather than waiting for symptoms, is the backbone of STI control in young people. This topic explains how STI burden is measured in adolescents and the logic and structure of age-based screening.

Definition

STI epidemiology in adolescents is the study of how often sexually transmitted infections occur and are distributed in young populations; STI screening is the routine testing of asymptomatic but sexually active individuals to detect and treat infection before symptoms or complications arise.

Scope

The topic covers measures of STI frequency (incidence, prevalence) and their concentration in adolescents and young adults; the role of asymptomatic infection in driving transmission; the rationale for routine screening; and the broad shape of screening recommendations (who, how often, and which infections). It is descriptive and population-level, and does not provide individual testing or treatment instructions.

Core questions

• How is STI burden quantified, and how is it distributed by age?
• Why does asymptomatic infection make screening, rather than symptom-based testing, necessary?
• Which adolescents are recommended for routine screening, and for which infections?
• What outcomes is screening intended to prevent?

Key concepts

• Incidence and prevalence
• Age-concentrated STI burden
• Asymptomatic infection
• Routine (opt-out) screening
• Nucleic acid amplification testing
• Reproductive sequelae as the target of prevention
• Confidential adolescent testing

Mechanisms

Screening interrupts transmission and prevents complications by detecting infections that would otherwise remain undiagnosed. Because many chlamydial and gonococcal infections in adolescents are asymptomatic, symptom-triggered testing misses much of the prevalent disease; routine testing of sexually active young people identifies these silent infections so they can be treated and onward transmission and sequelae (such as pelvic inflammatory disease) reduced. Sensitive, non-invasive nucleic acid amplification tests on urine or self-collected swabs make population-level screening feasible and acceptable.

Clinical relevance

This topic frames why screening programmes exist and how their target populations are defined, which is essential for appraising STI guidelines and surveillance data. It is educational reference material describing population strategy and does not prescribe testing intervals or management for any individual.

Epidemiology

National prevalence and incidence estimates show STIs concentrated in adolescents and young adults; Satterwhite and colleagues quantified this burden for the United States. On this basis, the US Preventive Services Task Force and professional bodies recommend routine chlamydia and gonorrhea screening for sexually active young women, and guidelines address screening of other groups and infections, reflecting both high prevalence and the predominance of asymptomatic disease.

History

Adolescent STI screening expanded substantially after nucleic acid amplification testing replaced culture for chlamydia and gonorrhea, allowing accurate detection from urine and self-collected specimens. This technical shift, combined with surveillance documenting the youth concentration of infection, drove successive editions of national screening and treatment guidance.

Debates

How broadly should routine screening extend, and at what interval?

Recommendations consistently support routine chlamydia and gonorrhea screening for sexually active young women, but the optimal frequency, the case for screening young men and extragenital sites, and the balance against costs and over-testing remain matters of ongoing guideline debate.

Seminal works

• satterwhite-2013
• uspstf-2021-chlamydia
• aap-2014-screening

Frequently asked questions

Why screen adolescents who feel well?

Because many STIs, especially chlamydia, are asymptomatic in young people; routine screening detects and allows treatment of these silent infections before they cause complications or are passed on.

Which STIs are most commonly targeted by adolescent screening?

Routine screening of sexually active young women most prominently targets chlamydia and gonorrhea, with additional recommendations for HIV and, in some groups, other infections.